CRISPR Therapeutics vs Envoya
CRISPR Therapeutics vs Envoya, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Envoya on 46/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 46/100
- agent readiness: 44/100 against 21/100
- domain rating: 67/100 against 13/100
- funding raised: $547M against $2.0M
Envoya
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CRISPR Therapeutics | Envoya |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | Developing polymer-based nanoparticles for targeted gene therapy delivery. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Life Sciences, Nanotechnology, Genetics, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2013 | 2021 |
| Headquarters | Zug, Switzerland | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | Envoya |
|---|---|---|
| Employees | Not published | 10 |
| Total funding | $547M | $2.0M |
| Latest round | Series B | Pre-Seed |
| LinkedIn followers | Not published | 1,073 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | Envoya |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 46/100 |
| Traction | 40/100 | 42/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 13/100 | 27/100 |
| Quality | 88/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | Envoya |
|---|---|---|
| Hosting | Self Managed | Netlify |
| CDN | Not detected | Netlify |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs Envoya: common questions
Which is better, CRISPR Therapeutics or Envoya?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and Envoya compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 46/100), agent readiness (44/100 against 21/100), domain rating (67/100 against 13/100), funding raised ($547M against $2.0M).
Read the full CRISPR Therapeutics review and pricing or the Envoya review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.